According to FutureWise analysis the market for Angiogenesis Assays in 2023 is US$ 2.15 billion, and is expected to reach US$ 4.36 billion by 2031 at a CAGR of 9.20%.
Angiogenesis is the process of the formation of new capillary blood vessels, which plays a crucial role in various pathological processes, like tissue development and wound healing. However, it also underlies several abnormal conditions, including tumor growth and metastasis. Abnormal blood vessel growth can cause many deadly and debilitating diseases, including cancer, stroke, cardiovascular disease, and diabetic and age-related blindness. The mechanisms of chronic inflammation, including the secretion of pro-inflammatory cytokines and the formation of reactive oxygen species (ROS), can also stimulate the formation of new blood vessels in tumor progression. Angiogenic signaling pathway in tumors is similar to normal angiogenesis, involving soluble growth factors, membrane-bound receptors, and cell-cell and cell-matrix interactions. Such signaling regulates cell migration, which is crucial to angiogenesis.
The tube formation assay is one of the most commonly used in vitro assays to model the reorganization phase of angiogenesis. The assay estimates the capacity of endothelial cells, plated at lower densities with the appropriate extracellular matrix support, to form capillary-like structures (i.e., tubes). Scientists generally employ this assay to determine the capability of various compounds to promote or inhibit tube formation. Compounds that can inhibit tube formation could be useful in various diseases, such as cancer, where tumors stimulate new blood vessel formation to receive oxygen and nutrients to grow beyond a relatively small size. Upon plating, endothelial cells attach and generate mechanical forces on the surrounding extracellular support matrix to create tracks or guidance pathways that facilitate cellular migration. The resulting cords of cells will eventually form hollow lumens.
FutureWise Market Research has published a report that provides an insightful analysis angiogenesis assays market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.
According to the analysis conducted by FutureWise research analysts, angiogenesis assays market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.